NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

China Restricts Co-Founders of Manus Amid Regulatory Review of Meta's $2 Billion Acquisition

Manus, a Singapore-based artificial intelligence startup, is facing a regulatory review by China's National Development and Reform Commission (NDRC) following Meta's acquisition of the firm for a reported $2 billion to $3 billion in December.

According to the Financial Times, Manus's co-founders Xiao Hong and Ji Yichao were summoned to a meeting in Beijing this month, where they were informed that they are not allowed to leave the country while the regulatory review is underway. However, they remain free to travel within China.

Manus is actively seeking law firms and consultancies to help resolve the matter. The company's AI agents, which can operate as digital employees, execute tasks such as research and automation independently with minimal prompts.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

China's commerce ministry had earlier announced that it would assess and investigate Meta's acquisition of Manus. The Ministry of Public Security and Meta have not commented on the matter, while Reuters was unable to verify the report.

Investor Takeaway

Investors should be cautious of potential regulatory risks associated with international acquisitions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.